After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Royalty Pharma plc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Royalty Pharma plc is $21.20B. A total of 2.94 million shares were traded on the day, compared to an average of 4.41M shares.
In the most recent transaction, Norden Gregory sold 33,500 shares of RPRX for 36.23 per share on Aug 11 ’25. After the transaction, the Director now owns 194,848 company shares. In a previous transaction on Aug 11 ’25, Norden Gregory bought 33,500 shares at 36.23 per share.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Royalty Pharma plc pays an annual dividend of $0.86, resulting in a dividend yield of 2.37%, and it has a price to earnings (P/E) ratio of 15.82.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, RPRX has a high of $38.00 and a low of $24.05.
As of this writing, RPRX has an earnings estimate of $1.05 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $1.16 per share and a lower estimate of $0.87. The company reported an EPS of $1.04 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RPRX’s latest balance sheet shows that the firm has $2.80B in Cash & Short Term Investments as of fiscal 2021. There were $7.10B in debt and $171.25M in liabilities at the time. Its Book Value Per Share was $14.68, while its Total Shareholder’s Equity was $10.25B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RPRX is Buy with a score of 4.29.
